IP Library Assignment 060390/0122
Patent Assignment
Reel/Frame 060390/0122

Change of Name

Recorded: 2022-06-20 Pages: 13
Assignor
UNIVERSITE DE PARIS
Executed: 2022-03-04
Assignee
UNIVERSITÉ PARIS CITÉ
85 BOULEVARD SAINT-GERMAIN, PARIS, 75006, FRANCE
Covered Properties (205)
Methods and Pharmaceutical Compositions for the Treatment of Systemic Mastocytosis
Application: 17/324,690 →
Publication: US US20210308106A1
Ex Vivo Generation of Gamma Delta FOXP3+ Regulatory T Cells and Therapeutic Uses Thereof
Application: 16/320,764 →
Publication: US US20190161729A1
CD31 Peptides
Application: 14/408,789 →
Publication: US US20150203536A1
Organic Electrochemical Transistor Based Sensor
Application: 17/639,996 →
Publication: US US20220334078A1
Novel Anti-CD25 Antibodies
Application: 17/612,347 →
Publication: US US20220251232A1
METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
Application: 17/616,512 →
Publication: US US20220233673A1
Neutralizing Granzyme B for Providing Cardioprotection in a Subject Who Experienced a Myocardial Infarction
Application: 17/632,271 →
Publication: US US20220275105A1
Use of Receptor-Binding Domain Derived from Bovine Leukemia Virus for the Diagnosis or Treatment of Cationic L-Amino Acid Transporter-Related Diseases
Application: 15/777,087 →
Publication: US US20180335435A1
Method of Generation of a State Indicator of a Person in Coma
Application: 16/982,174 →
Publication: US US20210022638A1
Methods and Compositions for Treating PAX6-Deficiency Related Disease
Application: 17/637,682 →
Publication: US US20220265659A1
Use of Pyrvinium for the Treatment of a Ras Pathway Mutated Acute Myeloid Leukemia
Application: 17/639,477 →
Publication: US US20220288040A1
A Method for Measuring the Speed of Sound in Liver with a Moving Probe and Associated Methods and Devices
Application: 17/763,268 →
Publication: US US20220346748A1
Methods for the Treatment of Adult T-Cell Leukemia/Lymphoma
Application: 17/760,557 →
Publication: US US20220348660A1
Genetically Modified Human Stem Cell Expressing a Mutant Human Cytochrome P450 2B6 Protein and Use Thereof in the Treatment of Cancer
Application: 17/768,016 →
Publication: US US20220409668A1
Methods of Determining Whether Patients Suffering from Acute Myeloid Leukemia Will Achieve a Response to an Myc-Targeting Therapy
Application: 17/764,642 →
Publication: US US20220356525A1
Dipole Element for Superconducting Circuits
Application: 16/751,982 →
Publication: US US20210234086A1
Determination of Health Status of Systems Equipped with Sensors
Application: 17/229,899 →
Publication: US US20210321956A1
Method for Measuring Several Wavefronts Incoming from Different Propagation Directions
Application: 17/487,313 →
Publication: US US20220099499A1
Novel Hydrazone Derivatives For Preventing Or Treating EBV-Related Cancers
Application: 17/045,049 →
Publication: US US20210161887A1
Generation and Detection of Terahertz Radiation with an Arbitrary Polarization Direction
Application: 17/043,774 →
Publication: US US20210018364A1
Method for Spacetime-Constrained Oblivious Transfer
Application: 17/043,300 →
Publication: US US20210021414A1
Methods for the Treatment of Retinal Dystrophies by Exon-Skipping Strategy
Application: 17/606,574 →
Publication: US US20220340901A1
Detection of Platelet-Derived Shed CD31
Application: 15/358,213 →
Publication: US US20170067910A1
Wave Shaping Device, an Electronic Device, and a System
Application: 17/571,986 →
Publication: US US20220131624A1
Synergistic Combination of Biomarkers for Detecting and Assessing Hepatic Fibrosis
Application: 17/226,129 →
Publication: US US20210239713A1
Vascular Catheter Permitting the Injection of a Volume of the Plug Type
Application: 15/576,417 →
Publication: US US20180147389A1
Immunogenic Construct Comprising an Ebv-Cell Antigen and a Targeting Moiety and Applications Thereof
Application: 16/061,807 →
Publication: US US20180360950A1
Compositions Comprising Secreted Extracellular Vesicles of Cells Expressing NFATC4 Useful for the Treatment of Cancer
Application: 16/089,754 →
Publication: US US20190117688A1
New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
Application: 17/605,524 →
Publication: US US20220280655A1
Electrochemical System for the Selective Reduction of Carbon Monoxide into Methanol
Application: 17/605,600 →
Publication: US US20220228274A1
INDUCING IMMUNE TOLERANCE BY rAAV VECTORS
Application: 17/610,840 →
Publication: US US20220213505A1
Detection of Hypermethylated Genes for Diagnosing Pancreatic Cancer
Application: 17/595,776 →
Publication: US US20220098680A1
Methods of Inducing or Restoring Immune Tolerance
Application: 17/605,594 →
Publication: US US20220168394A1
Device for Calculating, During One Step or Each Successive Step of the Gait of a Subject, the Push-Off P0 of the Subject
Application: 17/605,503 →
Publication: US US20220338759A1
Use of Jak Inhibitors for the Treatment of Painful Conditions Involving NAV1.7 Channels
Application: 17/604,109 →
Publication: US US20220202820A1
Methods of Predicting and Preventing Cancer in Patients Having Premalignant Lesions
Application: 17/600,957 →
Publication: US US20220177978A1
Methods for the Treatment of Keloid, Hypertrophic Scars and/or Hyperpigmentation Disorders
Application: 17/599,210 →
Publication: US US20220249511A1
Bifunctional Vectors Allowing BCL11A Silencing and Expression of an Anti-Sickling Hbb and Uses Thereof for Gene Therapy of B-Hemoglobinopathies
Application: 17/441,466 →
Publication: US US20220160788A1
New Inhibitors of LRRK2/PP1 Interaction
Application: 17/439,641 →
Publication: US US20220154153A1
Imidazoline Derivatives as CXCR4 Modulators
Application: 17/599,785 →
Publication: US US20220144853A1
Use of an Agent Capable of Inhibiting the Activation of Mait Cells for the Treatment of Obesity and Obesity-Related Disorders
Application: 17/440,351 →
Publication: US US20220184083A1
Inhibitors of Ngal Protein
Application: 17/434,535 →
Publication: US US20220054493A1
Recombinant Vectors Suitable for the Treatment of Ipex Syndrome
Application: 17/428,401 →
Publication: US US20220136006A1
Methods and Compositions for Modulating Blood-Brain Barrier
Application: 17/428,396 →
Publication: US US20220117911A1
Methods and Compositions for Identifying Whether a Subject Suffering from a Cancer Will Achieve a Response with an Immune-Checkpoint Inhibitor
Application: 17/426,856 →
Publication: US US20220107323A1
Non-Human Animal Models of SéZary Syndrome
Application: 17/424,973 →
Publication: US US20220087233A1
mRNA-BASED BIOMARKERS FOR ANTIBODY-MEDIATED TRANSPLANT REJECTION
Application: 17/420,347 →
Publication: US US20220081715A1
Use of Agents Capable of Inducing LC3-Associated Phagocytosis for Treating Sustained Inflammation in Patients Suffering from Chronic Liver Disease
Application: 17/422,227 →
Publication: US US20220081481A1
Variants of Erythroferrone and Their Use
Application: 17/423,775 →
Publication: US US20220119516A1
Methods for Screening Inhibitors Against Chikungunya Virus and for Determining Whether Subjects Are Predisposed to Infection by Said Virus
Application: 17/421,999 →
Publication: US US20220098681A1
In Vitro Method for Determining the Likelihood of Occurrence of an Acute Microvascular Rejection (Amvr) Against a Renal Allograft in an Individual
Application: 17/421,987 →
Publication: US US20220404356A1
Treatment and Prediction of Therapeutic Responses in Patients Suffering from Friedreich Ataxia
Application: 17/418,981 →
Publication: US US20220105073A1
Mucosal-Associated Invariant T (Mait) Cells Expressing Chimeric Antigen Receptors
Application: 17/414,689 →
Publication: US US20220016171A1
System for Controlled Depositing of a Fluid on a Substrate
Application: 17/415,595 →
Publication: US US20220063192A1
Method for Manufacturing a Superconducting Lc-Type Resonator and Superconducting Resonator Thus Obtained
Application: 17/312,842 →
Publication: US US20220037757A1
Nanoparticles for Preparing Regulatory B Cells
Application: 17/297,207 →
Publication: US US20220031628A1
Recombinant Vectors Suitable for the Treatment of Ipex Syndrome
Application: 17/295,093 →
Publication: US US20220017919A1
Treatment of Diseases Associated with Biliary System Destruction
Application: 17/283,843 →
Publication: US US20210379003A1
Use of Cilengitide for Ameliorating Cardiac Fibrosis Occurring in Response to Myocardial Infarction
Application: 17/282,599 →
Publication: US US20210347898A1
Method to Restore or Improve Cognitive Functions
Application: 17/282,474 →
Publication: US US20210379146A1
Preparation Method for Ecteinascidin Compound and Intermediate Thereof
Application: 17/283,012 →
Publication: US US20210355132A1
Methods and Pharmaceutical Composition for the Treatment of Mucosal Inflammatory Diseases
Application: 17/282,580 →
Publication: US US20210340278A1
Infigratinib for Treatment of FGFR3-Related Skeletal Diseases During Pregnancy
Application: 17/280,620 →
Publication: US US20220040175A1
Calibration Standard for Evanescence Microscopy
Application: 17/275,409 →
Publication: US US20220178828A1
Methods for Increasing Fetal Hemoglobin Content in Eukaryotic Cells and Uses Thereof for the Treatment of Hemoglobinopathies
Application: 17/274,966 →
Publication: US US20220033856A1
Combination of HER2/Neu Antibody with Heme for Treating Cancer
Application: 17/274,592 →
Publication: US US20220047701A1
Use of an Inhibitor of NTSR1 Activation or Expression for Preventing Weight Loss, Muscle Loss, and Protein Blood Level Decrease in Subjects in Need Thereof
Application: 17/274,597 →
Publication: US US20220048995A1
Methods for the Treatment of Neurofibromatosis
Application: 17/274,600 →
Publication: US US20220047567A1
Methods and Compositions for Promoting Wound Healing in a Subject Suffering from Ectodermal Dysplasias
Application: 17/258,894 →
Publication: US US20210322418A1
Amphiphilic and Mesogenic Organic Dyes for Tailor-Made Reflective Low-Dimensional Materials
Application: 17/257,031 →
Publication: US US20210122742A1
Device For Imaging Blood Vessels
Application: 17/253,778 →
Publication: US US20210275088A1
Methods for Treating Gram Positive Bacterial Infection
Application: 17/052,383 →
Publication: US US20210169985A1
Methods for Predicting Outcome and Treatment of Patients Suffering from Prostate Cancer or Breast Cancer
Application: 17/047,269 →
Publication: US US20210164984A1
Antigenic Peptides Deriving from Secretogranin V and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes
Application: 16/981,352 →
Publication: US US20210070819A1
Antigenic Peptides Deriving from PCSK2 and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes
Application: 16/981,462 →
Publication: US US20210023209A1
Antigenic Peptides Deriving from Urocortin 3 and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes
Application: 16/981,474 →
Publication: US US20210024603A1
Method for Identifying One or More Mutations in a Hotspot Mutation Sequence
Application: 16/980,657 →
Publication: US US20210024984A1
Methods for Prognosing and Treating Metabolic Diseases
Application: 16/977,274 →
Publication: US US20210000889A1
Optical Imaging Agents Targeting Inflammation
Application: 16/968,272 →
Publication: US US20200368373A1
Method and Apparatus for Simultaneous 4D Ultrafast Blood Flow and Tissue Doppler Imaging of the Heart and Retrieving Quantification Parameters
Application: 16/970,810 →
Publication: US US20210077065A1
Antibody Against the Endothelin Receptor Subtype a, and Uses Thereof
Application: 16/967,763 →
Publication: US US20220089755A1
Methods and Pharmaceutical Compositions for the Treatment of FGFR3-Related Chondrodysplasias
Application: 16/964,781 →
Publication: US US20210052546A1
Biomarkers for Typing Allograft Recipients
Application: 16/958,240 →
Publication: US US20200400685A1
New Antibiotics Targeting Mycobacteria
Application: 16/956,300 →
Publication: US US20200325139A1
New Beta-Lactamase Inhibitors Targeting Gram Negative Bacteria
Application: 16/956,304 →
Publication: US US20210300926A1
Double-Stranded Dna Molecule for the Detecting and Characterizing Molecular Interactions
Application: 16/955,596 →
Publication: US US20230054300A1
Vaccine Composition for Classical Swine Fever and Preparation Method Thereof
Application: 16/770,190 →
Publication: US US20200289641A1
Use of Triethylenetetramine (Teta) for the Therapeutic Induction of Autophagy
Application: 16/768,346 →
Publication: US US20200360305A1
New Method for Treating Dengue Virus Infection
Application: 16/765,365 →
Publication: US US20200352913A1
Improved Method for Quantifying Balance
Application: 16/763,573 →
Publication: US US20200375520A1
Method For Detecting Abnormal Values Of A Biomarker
Application: 16/763,815 →
Publication: US US20200388388A1
Treatment of Her-2 Dependent Cancer Using an Agent That Modulates the Activity of a Mirna
Application: 16/758,274 →
Publication: US US20200339986A1
Diagnosis and/or Prognosis of HER2-Dependent Cancer Using One or More Mirna as a Biomarker
Application: 16/758,624 →
Publication: US US20200347457A1
Diagnosis and/or Prognosis of HER2-Dependent Cancer Using Moesin as a Biomarker
Application: 16/758,644 →
Publication: US US20200308652A1
Radio Frequency Oscillator
Application: 16/756,799 →
Publication: US US20210058033A1
Compositions for Treating Macular Edema
Application: 16/642,642 →
Publication: US US20200254069A1
Methods for Determining Whether a Patient Suffering from Rhabdomyolysis Achieves a Response with a TLR9 Antagonist
Application: 16/633,912 →
Publication: US US20210087633A1
Use of Phenothiazine Derivative in the Treatment of Infection Caused by Bacteria Carrying Type Iv Pili
Application: 16/628,687 →
Publication: US US20200222418A1
Use of Phenothiazine Derivative in the Treatment of Infectious Purpura or Purpura Fulminans
Application: 16/347,208 →
Publication: US US20200054646A1
Gelling Formulation Based On Calcium Gluconate
Patent: 9,925,266 →
Application: 14/381,316 →
Publication: US US20150005380A1
Expression Vector for Cholesterol 24 -Hydrolase in Therapy of Huntington's Disease
Patent: 9,132,173 →
Application: 13/878,845 →
Publication: US US20130209410A1
Training Device for Rugby Players
Patent: 9,061,189 →
Application: 13/577,634 →
Publication: US US20130203030A1
Method of Digital Multiplex Detection and/or Quantification of Biomolecules and Use Thereof
Application: 17/614,023 →
Publication: US US20220356520A1
Method of Providing Celiprolol Therapy to a Patient
Application: 17/472,499 →
Publication: US US20220062208A1
High-Fidelity Long-Term Storage of Biological Material
Application: 16/757,013 →
Publication: US US20200337299A1
Detection of Bioprosthetic Valve Degeneration
Application: 16/675,806 →
Publication: US US20200147264A1
Methods for the Treatment of Mitochondrial Genetic Diseases
Application: 16/497,704 →
Publication: US US20210275543A1
CAPPED CYCLODEXTRIN-HYDROPHOBIC MOIETY CONJUGATE, CYCLODEXTRIN SUPRAMOLECULAR POLYMER, AND CYCLODEXTRIN-siRNA COMPLEX AND METHOD OF SYNTHESIS THEREOF
Application: 16/329,423 →
Publication: US US20200010576A1
Mobile Robotic System for Guiding an Automated Vehicle Along a Reconfigurable Path and Method Thereof
Application: 16/124,459 →
Publication: US US20190004521A1
Methods of Treating Sepsis with Synaptic Vesicle 2A and/or 2B Binding Chemical Entities
Application: 16/302,723 →
Publication: US US20200121644A1
Ultrafine Nanoparticles as an Imaging Agent for Diagnosing a Renal Disorder
Application: 16/069,728 →
Publication: US US20190022257A1
Method of Culturing Segmented Filamentous Bacteria in Vitro
Application: 16/548,280 →
Publication: US US20190367867A1
Nitrogen-Containing Analogs of Salinomycin, Synthesis and Use Against Cancer Stem Cells and Malaria
Application: 15/510,427 →
Publication: US US20170253610A1
Method for Predicting Responsiveness to a Treatment with an Egfr Inhibitor
Application: 14/360,311 →
Publication: US US20140370029A1
Multiphoton Activable Quinoline Derivatives, Their Preparation and Their Uses
Patent: 8,993,767 →
Application: 13/521,936 →
Publication: US US20130116281A1
Device for Causing and/or Rehabilitating the Binocular Motivity of a Patient
Patent: 8,851,669 →
Application: 13/515,792 →
Publication: US US20120320336A1
Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer
Patent: 8,529,900 →
Application: 12/934,191 →
Publication: US US20110044906A1
Allergen Desensitization Method
Patent: 9,539,318 →
Application: 12/745,870 →
Publication: US US20100260821A1
Use of Celiprolol for Treating Vascular Ehlers-Danlos Syndrome in Women During Pregnancy and Peripartum Period
Application: 16/184,903 →
Publication: US US20190192456A1
Use of Celiprolol for Treating Vascular Ehlers-Danlos Syndrome in Women During Pregnancy and Peripartum Period
Application: 16/879,511 →
Publication: US US20210137859A1
Allergen Desensitization Method
Application: 15/367,078 →
Publication: US US20170128566A1
A Sers Method for Analyzing a Viscous Biofluid
Application: 17/762,760 →
Publication: US US20220349902A1
Optical Lithography Process Adapted for a Sample Comprising at Least One Fragile Light Emitter
Application: 16/483,492 →
Publication: US US20190369500A1
Methods and Pharmaceutical Compositions for Modulating Autophagy
Application: 16/648,744 →
Publication: US US20200268837A1
Allergen Desensitization Method
Application: 16/036,919 →
Publication: US US20180318413A1
Allergen Desensitization Method
Application: 16/395,206 →
Publication: US US20190314495A1
Allergen Desensitization Method
Application: 16/937,444 →
Publication: US US20200353072A1
Allergen Desensitization Method
Application: 17/523,648 →
Publication: US US20220241405A1
Immunotherapeutic Method for Increasing Groundnut Tolerance in a Subject
Patent: 8,202,533 →
Application: 12/628,077 →
Publication: US US20100136093A1
Means for Diagnosing, Predicting or Monitoring Pneumocystis Pneumonia
Application: 17/552,130 →
Publication: US US20220119886A1
Plasmic Production and Expression of Recombinant Proteins in Cells Grown Without Antibiotics
Patent: 8,440,455 →
Application: 12/675,011 →
Publication: US US20110129487A1
Use of CD9 as a Biomarker and as a Biotarget in Glomerulonephritis or Glomerulosclerosis
Application: 17/616,497 →
Publication: US US20220229072A1
Nrp-1 Binding Inhibitory Peptides and Uses Thereof
Application: 17/618,233 →
Publication: US US20220169677A1
Anti-Protease Nexin-1 Conformational Single Domain Antibodies and Uses Thereof to Control Bleeding
Application: 17/620,381 →
Publication: US US20220259295A1
Detection of Relb Activation for Predicting a Prognostic in B-Cell Lymphoma
Application: 17/596,758 →
Publication: US US20220298578A1
Novel Inhibitors of Kallikrein Proteases and Uses Thereof
Application: 17/627,378 →
Publication: US US20220267379A1
Atomic Force Microscope
Application: 17/627,239 →
Publication: US US20220236301A1
Antibodies Having Specificity for CD38 and Uses Thereof
Application: 17/627,674 →
Publication: US US20220251234A1
Methods for Inducing Full Ablation of Hematopoiesis
Application: 17/627,771 →
Publication: US US20220265781A1
Methods for Adhering Tissue Surfaces and Materials and Biomedical Uses Thereof
Application: 15/102,541 →
Publication: US US20160325010A1
Fusion Proteins and Immunoconjugates and Uses Thereof Which Are Specific for Glycophorin A
Patent: 9,879,090 →
Application: 14/772,339 →
Publication: US US20160083481A1
Subunit Vaccine Platform Based on Multimeric Ribonucleoproteins Comprising Nucleoproteins of a Non-Segmented Negative-Strand Rna Virus as Carriers of Heterologous Polypeptides
Application: 15/034,870 →
Publication: US US20160271242A1
Combination of an Arsenic Compound and at Least One Retinoid for Treating Acute Myeloid Leukemia
Application: 15/107,749 →
Publication: US US20160317579A1
Use of Cranberry Proanthocyanidin for Treatment of Oropharyngeal Bacterial Colonization
Application: 15/303,118 →
Publication: US US20170028006A1
Porphyrin Molecular Catalysts for Selective Electrochemical Reduction of CO2 into Co
Application: 15/309,035 →
Publication: US US20170067168A1
Method for Obtaining a Functional Parameter of a Muscle
Application: 15/325,103 →
Publication: US US20170181729A1
Methods and Pharmaceutical Compositions for the Treatment of Fibrosis
Application: 15/512,872 →
Publication: US US20170239242A1
Time-Controlled Glucose Releasing Hydrogels and Applications Thereof
Patent: 9,931,433 →
Application: 15/520,603 →
Publication: US US20170304489A1
Methods and Pharmaceutical Compositions for the Treatment of Cancer
Application: 15/525,771 →
Publication: US US20180296549A1
Method for Tuning One or More Resonator(S)
Patent: 9,995,929 →
Application: 15/557,950 →
Publication: US US20180059412A1
Human Monoclonal Antibodies Against Orexin Receptor Type 1
Application: 15/543,371 →
Publication: US US20180002421A1
Polypeptides for Engineering Integrase Chimeric Proteins and Their Use in Gene Therapy
Application: 16/432,107 →
Publication: US US20190337990A1
Ptgdr-1 and/or Ptgdr-2 Antagonists for Preventing and/or Treating Systemic Lupus Erythematosus
Application: 16/846,611 →
Publication: US US20200261413A1
Methods of Administering Neutralizing Anti-Protease Nexin-1 Antibodies to Treat Hemophilia A
Application: 15/565,933 →
Publication: US US20180105603A1
Method for Fat Characterization Using MRI Images Acquired Using a Multiple Gradient-Echo Sequence with Bipolar Gradients
Application: 15/568,839 →
Publication: US US20180098711A1
Methods and Pharmaceutical Compositions for the Treatment of Bacterial Infections in Patients Suffering from Cirrhosis
Application: 15/571,971 →
Publication: US US20180140597A1
Anti-Mullerian Hormone (Amh) Neutralizing Antibodies and Uses Thereof
Application: 15/761,240 →
Publication: US US20180258167A1
Method for Obtaining a Numerical Model Associating an Objective Measurement to a Subjective Sensation Using Ultrasound Imaging Technique and Associated Device
Application: 15/761,486 →
Publication: US US20180261127A1
Immunological Signatures and Parameters Predicting Therapeutic Responses to Anti-Tnf Therapy
Application: 15/761,238 →
Publication: US US20180267058A1
A Method for Analyzing the Activity of an Ion Channel
Application: 15/776,685 →
Publication: US US20180356430A1
Use of Aac-11 Inhibitors for the Treatment of Viral Infection
Application: 16/075,224 →
Publication: US US20190046610A1
Detector for Terahertz Electromagnetic Waves
Application: 16/085,437 →
Publication: US US20190078938A1
Novel Derivatives and Their Use as Selective Inhibitors of Caspase-2
Application: 16/087,346 →
Publication: US US20190100508A1
A Bacteriophage Strain Capable of Producing a Lytic Infection in the Escherichia Coli ST131-O25B:H4 Clone
Application: 16/093,361 →
Publication: US US20190119652A1
Methods and Kits for the Rapid Detection of the Escherichia Coli O25B-ST131 Clone
Application: 16/093,202 →
Publication: US US20190120838A1
Methods and Kits for Analysing the Steady-State Activation or Inhibition of Itam Signalling of Immunoreceptors in Blood Leukocytes
Application: 16/308,299 →
Publication: US US20190265232A1
Methods for Predicting Acute Severe Colitis Treatment Response
Application: 16/309,699 →
Publication: US US20190136324A1
Method for Analyzing the Ability of a Substance to Cross a Bilayer Membrane
Application: 16/315,452 →
Publication: US US20190242914A1
A Method for Post-Processing Liver Mri Images to Obtain a Reconstructed Map of the Internal Magnetic Susceptibility
Application: 16/332,749 →
Publication: US US20210287359A1
Organic Materials with Special Optical Effects
Application: 16/473,782 →
Publication: US US20190337885A1
Methods and Pharmaceutical Compositions for the Treatment Patients Suffering from Myeloproliferative Disorders
Application: 16/478,662 →
Publication: US US20190374611A1
Electron-Beam Lithography Process Adapted for a Sample Comprising at Least One Fragile Nanostructure
Application: 16/486,061 →
Publication: US US20200006037A1
Method for Imaging an Area of a Medium with Ultrasound Contrast Agents and Associated Device
Application: 16/495,562 →
Publication: US US20200107817A1
Methods and Pharmaceutical Compositions for the Treatment of Acute Ischemic Stroke
Application: 16/613,851 →
Publication: US US20200138919A1
Immobilization of Membrane Proteins Onto Supports via an Amphiphile
Patent: 8,207,263 →
Application: 12/514,656 →
Publication: US US20090275066A1
Immobilization of Membrane Proteins Onto Supports via an Amphiphile
Patent: 8,674,044 →
Application: 13/479,890 →
Publication: US US20130023026A1
Method for Characterizing the Development of Pathologies Involving Changes in Volumes of Bodies, Notably Tumors
Patent: 9,026,195 →
Application: 13/323,000 →
Publication: US US20120220856A1
Three-Dimensional Lc Electrical Resonator Device
Application: 15/553,034 →
Publication: US US20180248247A1
Force Sensor
Application: 15/752,415 →
Publication: US US20190011317A1
Method for Producing Erythrocyte Proteins
Application: 15/768,715 →
Publication: US US20190023765A1
Method of Treatment of Human Papillomaviruses Related Chronic Infections
Application: 16/303,824 →
Publication: US US20200308269A1
Method and Acoustic Device for Measuring Surface Movements
Application: 16/319,445 →
Publication: US US20190331793A1
Synthesis of Core-Shell Nanoparticles and Applications of Said Nanoparticles for Surface Enhanced Raman Scattering
Application: 16/341,762 →
Publication: US US20200048788A1
Minibeam Radiotherapy Device
Application: 16/349,938 →
Publication: US US20190275350A1
Adaptive Generation of a High Dynamic Range Image of a Scene, on the Basis of a Plurality of Images Obtained by Non-Destructive Reading of an Image Sensor
Application: 16/478,404 →
Publication: US US20190379817A1
Method For Designing A Wind Turbine Or A Water Turbine Blade
Application: 16/486,009 →
Publication: US US20200049127A1
Iridium and / or Iridium Oxide Microsphere-Based Porous Material, Preparation Method Therefor, and Uses Thereof
Application: 16/617,227 →
Publication: US US20200087164A1
Immunological Treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Application: 16/519,683 →
Publication: US US20200048342A1
Immunological Treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Application: 15/514,173 →
Publication: US US20170247450A1
Use of Nanoporous Carbon Membranes for Separating Aqueous/Organic Mixtures
Application: 16/497,977 →
Publication: US US20210008504A1
A Microwave Oven
Application: 15/309,624 →
Publication: US US20170164429A1
Electroactive Ionic Liquids And Surface-Modified Substrates Containing Them
Application: 16/099,068 →
Publication: US US20190173078A1
Iron-Based Catalyst for Selective Electrochemical Reduction of CO2 into Co
Patent: 9,447,511 →
Application: 14/046,472 →
Publication: US US20150096899A1
Method for Post-Processing Magnetic Resonance Imaging Images in a Clinical Context
Application: 14/695,723 →
Publication: US US20160310035A1
Method and System for Spacetime-Constrained Oblivious Transfer
Application: 15/844,514 →
Publication: US US20180287788A1
Photochemical Composition and Use Thereof for Producing CH4 from CO2 and/or Co
Application: 15/879,650 →
Publication: US US20190224659A1
Correlation of Disease Activity with Clonal Expansions of Human Papillomavirus 16-Specific CD8+ T-Cells in Patients with Severe Erosive Oral Lichen Planus
Patent: 9,547,006 →
Application: 14/455,530 →
Publication: US US20150044252A1
Correlation of Disease Activity with Clonal Expansions of Human Papillomavirus 16-Specific CD8+ T-Cells in Patients with Severe Erosive Oral Lichen Planus
Application: 14/910,612 →
Publication: US US20160195531A1
Ex Vivo Generation of Mhcii Restricted CD4+FOXP3+ Regulatory T Cells and Therapeutic Uses Thereof
Application: 16/320,745 →
Publication: US US20190161728A1
Laser Source and Method of Manufacturing Such
Application: 16/342,173 →
Publication: US US20190252853A1
Preparation of Nanosuspension Comprising Nanocrystals of Active Pharmaceutical Ingredients with Little or No Stabilizing Agents
Application: 17/269,802 →
Publication: US US20210315831A1
Methods and Compositions for Treating Cancers
Application: 17/265,580 →
Publication: US US20210236633A1
Biocompatible Tolerogenic Nanoparticles
Application: 17/265,554 →
Publication: US US20210220481A1
Selective Porphyrin-Catalyzed Electrochemical Reduction of CO2 into Co, in Particular in Water
Application: 16/317,060 →
Publication: US US20190224660A1
Meclozine Derivatives and Diclazuril Derivatives for Use in the Prevention and/or the Treatment of Disorders Associated to the Inflammation Induced by P. Acnes
Application: 16/317,091 →
Publication: US US20190224191A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 20, 2015
From: CALIGIURI, GIUSEPPINA; NICOLETTI, ANTONINO
To: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE PARIS 13 ? PARIS NORD; ASSISTANCE PUBLIQUE ? HOPITAUX DE PARIS
Reel/Frame 034995/0636 →
Assignment of Assignor's Interest Feb 7, 2019
From: ZAGURY, DANIEL; LE BUANEC, HELENE; DUCHEZ, SOPHIE; SCHIAVON, VALERIE
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); MEDECINE ET INNOVATION; UNIVERSITE PARIS DIDEROT - PARIS 7; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
Reel/Frame 048263/0395 →
Assignment of Assignor's Interest Mar 9, 2020
From: LESCANNE, RAPHAEL; LEGHTAS, ZAKI
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; ECOLE NATIONALE SUPERIEURE DES MINES DE PARIS; ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPMENT DES METHODES ET PROCESSUS INDUSTRIELS - ARMINES; ECOLE NORMALE SUPERIEURE
Reel/Frame 052052/0075 →
Assignment of Assignor's Interest Aug 26, 2020
From: GIOVANNINI, DONATELLA; BELLIS, JULIEN; LEZAAR, JAWIDA; PETIT, VINCENT
To: METAFORA BIOSYSTEMS; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITÉ DE MONTPELLIER; UNIVERSITÉ PARIS DESCARTES - PARIS V
Reel/Frame 053601/0777 →
Employment Contract Aug 27, 2020
From: IVANOVA, SVILENA
To: METAFORA BIOSYSTEMS
Reel/Frame 054160/0084 →
Merger Sep 18, 2020
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 053820/0232 →
Assignment of Assignor's Interest Jan 7, 2021
From: HOLCMAN, DAVID; DOUMERGUE, ADRIEN; KUBIS, NATHALIE; RICHARD, ALEXANDRA
To: PARIS SCIENCES ET LETTRES - QUARTIER LATIN; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS; ÉCOLE NORMALE SUPÉRIEURE
Reel/Frame 054843/0982 →
Assignment of Assignor's Interest May 19, 2021
From: HERMINE, OLIVIER; GUILLEM, FLAVIA; DAMAJ, GANDHI; LADRAA, SOPHIA
To: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); FONDATION IMAGINE; UNIVERSITÉ PARIS DESCARTES; ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP)
Reel/Frame 056289/0977 →
Assignment of Assignor's Interest Jul 1, 2021
From: PITALÚA GARCÍA, DAMIÁN; KERENEDIS, IORDANIS
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITÉ DE PARIS
Reel/Frame 056737/0345 →
Merger Oct 20, 2021
From: UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 057844/0639 →
Assignment of Assignor's Interest Oct 25, 2021
From: PALPANAS, THEMIS; LINARDI, MICHELE; BONIOL, PAUL; RONCALLO, FEDERICO
To: UNIVERSITÉ DE PARIS; ÉLECTRICITÉ DE FRANCE
Reel/Frame 057902/0856 →
Merger Jan 12, 2022
From: UNIVERSITÉ PARIS-SUD
To: UNIVERSITÉ PARIS-SACLAY
Reel/Frame 058630/0874 →
Change of Name Jan 19, 2022
From: PARIS SCIENCES ET LETTRES - QUARTIER LATIN
To: PARIS SCIENCES ET LETTRES
Reel/Frame 058772/0593 →
Assignment of Assignor's Interest Jan 30, 2022
From: GUILLON, MARC; TESSIER, GILLES; WU, TENGFEI; BERTO, PASCAL
To: UNIVERSITE DE PARIS; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); SORBONNE UNIVERSITE
Reel/Frame 058822/0461 →
Assignment of Assignor's Interest Feb 11, 2022
From: BILLET, ANNE; SCHMIDT, FRÉDÉRIC; JOHANNES, LUDGER; SERVENT, DENIS
To: INSTITUT CURIE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); COMMISSARIAT Á L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (CEA)
Reel/Frame 058993/0304 →
Assignment of Assignor's Interest Mar 7, 2022
From: OLIVE, DANIEL; BENSUSSAN, ARMAND; GIUSTINIANI, JÉRÔME; FOUSSAT, ARNAUD
To: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); INSTITUT JEAN PAOLI & IRENE CALMETTES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITÉ D'AIX MARSEILLE
Reel/Frame 059186/0045 →
Assignment of Assignor's Interest Mar 10, 2022
From: ABERDAM, DANIEL; BREMOND-GIGNAC, DOMINIQUE; ROUX, LAURIANE; ASHERY PADAN, RUTH
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE PARIS; ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP); SORBONNE UNIVERSITE
Reel/Frame 059226/0118 →
Assignment of Assignor's Interest Mar 14, 2022
From: BLONDEL, MARC; QUILLEVERE, ALICIA; VOISSET, CÉCILE; LISTA, MARIA JOSÉ
To: UNIVERSITE DE BRETAGNE OCCIDENTALE; CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BREST; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Reel/Frame 059256/0884 →
Assignment of Assignor's Interest Mar 15, 2022
From: CAPITAO, DANY; MAURIN, ANTOINE; ABREU, CAROLINE; NOËL, VINCENT
To: VALOTEC; UNIVERSITE DE PARIS; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 059264/0880 →
Assignment of Assignor's Interest Mar 22, 2022
From: ASNAFI, VAHID; H, OLIVIE; MARÇAIS, AMBROISE; GHYSDAEL, JACQUES
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE PARIS; ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Reel/Frame 059333/0209 →
Assignment of Assignor's Interest Apr 1, 2022
From: AIT-OUFELLA, HAFID; DANCHIN, NICOLAS; SANTOS ZAS, ICIA; SIMON, TABASSOME
To: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP); SORBONNE UNIVERSITÉ; UNIVERSITÉ DE PARIS
Reel/Frame 059471/0168 →
Assignment of Assignor's Interest Apr 4, 2022
From: PERNOT, MATHIEU; DEFFIEUX, THOMAS; TANTER, MICKAEL; PAPADACCI, CLEMENT
To: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITE DE PARIS; SORBONNE UNIVERSITE
Reel/Frame 059486/0309 →
Assignment of Assignor's Interest Apr 14, 2022
From: TAMBURINI, JEROME; DECROOCQ, JUSTINE; SARRY, JEAN-EMMANUEL; BOUSCARY, DIDIER
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE TOULOUSE III - PAUL SABATIER; ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)
Reel/Frame 059600/0200 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 058630 Frame: 0874. Assignor(S) Hereby Confirms the Merger. May 4, 2022
From: UNIVERSITÉ PARIS-SUD
To: UNIVERSITÉ PARIS-SACLAY
Reel/Frame 059952/0787 →
Assignment of Assignor's Interest May 15, 2022
From: PUISSANT, ALEXANDRE; ITZYKSON, RAPHAEL
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP); UNIVERSITE DE PARIS
Reel/Frame 059908/0214 →